A novel peptide hormone has been identified as a potential marker for Alzheimer's disease, Type 2 Diabetes mellitus and Creutzfeldt-Jakob disease. A UK patent has been granted.

About

User friendly measurement of novel markers in saliva will help in both diagnosis and therapeutic monitoring of disease. I have identified a novel marker that is found in saliva and has also been shown to be present in the Alzheimer's brain. A UK patent has been granted for the use of this marker in both therapeutic and diagnostic settings

Key Benefits

The identified marker can be measured in saliva samples and as such this will allow the development of non-invasive diagnostic and therapeutic monitoring medical technologies.

Applications

The technology can be applied to both the diagnostic and pharmaceutical industries.

Register for free for full unlimited access to all innovation profiles on LEO

  • Discover articles from some of the world’s brightest minds, or share your thoughts and add one yourself
  • Connect with like-minded individuals and forge valuable relationships and collaboration partners
  • Innovate together, promote your expertise, or showcase your innovations